We are live on ! Find out more
AP

Atwood & Palmer Portfolio holdings

AUM $1.87B
1-Year Est. Return 24.22%
This Fund
S&P 500
This Quarter Est. Return
+4.23%
1 Year Est. Return
+24.22%
3 Year Est. Return
+82.33%
5 Year Est. Return
+97.89%
10 Year Est. Return
+352.71%
AUM
$1.12B
AUM Growth
+$54.5M
Cap. Flow
+$26.3M
Cap. Flow %
2.35%
Top 10 Hldgs %
29.48%
Holding
398
New
28
Increased
109
Reduced
39
Closed
2

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$17.6M
2
PYPL icon
PayPal
PYPL
+$8.22M
3
GILD icon
Gilead Sciences
GILD
+$7.14M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$2.62M
5
AVEM icon
Avantis Emerging Markets Equity ETF
AVEM
+$2.36M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$19.6M
2
URI icon
United Rentals
URI
+$6.93M
3
LMT icon
Lockheed Martin
LMT
+$2.69M
4
AAPL icon
Apple
AAPL
+$2.39M
5
VNLA icon
Janus Henderson Short Duration Income ETF
VNLA
+$805K

Sector Composition

Rank Sector Weight
1 Healthcare 18.15%
2 Technology 17.83%
3 Financials 12.37%
4 Industrials 9.95%
5 Consumer Discretionary 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PWR icon
251
Quanta Services
PWR
$100B
$28.5K ﹤0.01%
145
– –
EMBC icon
252
Embecta
EMBC
$208M
$28.5K ﹤0.01%
1,318
– –
PXD
253
DELISTED
Pioneer Natural Resource Co.
PXD
$28K ﹤0.01%
135
– –
PLD icon
254
Prologis
PLD
$130B
$27.2K ﹤0.01%
222
– –
NMRK icon
255
Newmark Group
NMRK
$2.66B
$26.5K ﹤0.01%
4,254
– –
PLMR icon
256
Palomar
PLMR
$3.63B
$26.1K ﹤0.01%
450
– –
OGE icon
257
OGE Energy
OGE
$9.67B
$25.9K ﹤0.01%
720
– –
DCPH
258
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$25.5K ﹤0.01%
1,811
– –
SLB icon
259
SLB Ltd
SLB
$76.5B
$25K ﹤0.01%
509
+125
+33% +$5.96K
MSI icon
260
Motorola Solutions
MSI
$78.7B
$24.9K ﹤0.01%
85
– –
GS icon
261
Goldman Sachs
GS
$301B
$24.8K ﹤0.01%
77
– –
DEO icon
262
Diageo
DEO
$51.6B
$24.8K ﹤0.01%
143
– –
MS icon
263
Morgan Stanley
MS
$336B
$24.8K ﹤0.01%
290
– –
VOO icon
264
Vanguard S&P 500 ETF
VOO
$1.01T
$24.4K ﹤0.01%
60
– –
MDRX
265
DELISTED
Veradigm Inc. Common Stock
MDRX
$24.3K ﹤0.01%
1,925
– –
CMG icon
266
Chipotle Mexican Grill
CMG
$42.7B
$23.5K ﹤0.01%
550
– –
VLO icon
267
Valero Energy
VLO
$87.2B
$23.5K ﹤0.01%
200
– –
CAH icon
268
Cardinal Health
CAH
$55.7B
$23.4K ﹤0.01%
247
– –
PFG icon
269
Principal Financial Group
PFG
$24.7B
$22.9K ﹤0.01%
302
– –
CCI icon
270
Crown Castle
CCI
$32.7B
$22.8K ﹤0.01%
+200
New +$23.8K
ALL icon
271
Allstate
ALL
$70.8B
$21.8K ﹤0.01%
200
– –
CODI icon
272
Compass Diversified
CODI
$810M
$21.7K ﹤0.01%
1,000
– –
APA icon
273
APA Corp
APA
$12.9B
$20.5K ﹤0.01%
600
– –
TNL icon
274
Travel + Leisure Co
TNL
$4.74B
$20.2K ﹤0.01%
500
– –
SHEL icon
275
Shell
SHEL
$248B
$19.6K ﹤0.01%
324
– –
9 10
11
12 13

Similar funds

PCP
Proficio Capital Partners Newton, Massachusetts $1.87B AUM 30.54% 1-Year Est. Return
JPG
Jordan Park Group San Francisco, California $1.88B AUM 16.2% 1-Year Est. Return
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
EPW
Evolve Private Wealth Los Angeles, California $1.87B AUM
P3I
Progeny 3 Inc Kirkland, Washington $1.87B AUM 30.4% 1-Year Est. Return
LPU
Lansdowne Partners (UK) London, United Kingdom $1.87B AUM 61.55% 1-Year Est. Return
SGF
S&G Foundation Wilson, Wyoming $1.88B AUM
TF
Trek Financial Scottsdale, Arizona $1.88B AUM 41.21% 1-Year Est. Return

Atwood & Palmer's Q2 2023 Portfolio in Review

As of Q2 2023, Atwood & Palmer held 398 positions worth $1.12B, up 5.1% from $1.06B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Atwood & Palmer's Q2 2023 filing shows 28 new, 109 increased, 39 reduced and 2 closed positions. Its largest new stake was Vertex Pharmaceuticals: 52,175 shares worth $18.4M. The largest sale was Amgen, an estimated $19.6M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 19% a quarter earlier, followed by Technology and Financials.

  • Atwood & Palmer's largest Q2 2023 buy was Vertex Pharmaceuticals: 52,175 shares worth $18.4M.
  • Atwood & Palmer added most to PayPal in Q2 2023, an estimated $8.22M increase.
  • Atwood & Palmer's biggest Q2 2023 reduction was Amgen, cutting an estimated $19.6M.
  • Atwood & Palmer fully exited First Trust Materials AlphaDEX Fund in Q2 2023, selling an estimated $217K.
  • Atwood & Palmer's ten largest holdings make up 29% of its $1.12B portfolio in Q2 2023.
  • Atwood & Palmer opened 28 new positions and closed 2 in Q2 2023.
  • Atwood & Palmer's portfolio value rose 5.1% quarter-over-quarter to $1.12B.

Based on Atwood & Palmer's 13F filing for Q2 2023, filed 18 Jul 2023.